Marta Klak, PhD has over eight years of experience in 3D bioprinting and currently serves as Chief Technology Officer and Head of Laboratory, overseeing all R&D activities. She leads the development of advanced products including bioinks and biomaterials for 3D bioprinting, flow-based bioreactor systems, UV-VIS curing technologies, and pancreatic organoid platforms. Her research focuses on tissue engineering and bioprinting technologies, with a strong emphasis on translating laboratory innovations into practical applications in regenerative medicine, pharmacology, and cosmetology. Dr. Klak has successfully managed several large-scale R&D projects and is recognized for her expertise in bridging biotechnology research with product development and commercialization.